This week HHS let compounding pharmacies make six popular peptides again, including BPC-157 and TB-500, while a formal rule is written. A compounding pharmacy founder told Joe Rogan why the FDA tried to ban over 50 of them. It all comes down to who pays the FDA's bills. By... 2022, 46% of its budget came from user fees paid by the drug companies it regulates. The peptides are only the beginning. Here's what nobody tells you about who funds the FDA: 🧵show more

The same FDA that said peptides had "no medical necessity" approved a new class of Alzheimer's drugs that failed to show efficacy and caused brain swelling or bleeding in 40% of participants. Here's how the FDA turned against America's health:

The six peptides are BPC-157, TB-500, epitalon, KPV, MOTS-c and semax.

It isn't FDA approval. It's a temporary policy for patient-specific compounding by licensed pharmacies and physicians, with registered manufacturers, testing and adverse-event reporting, while the agency works on a permanent rule.

BUHLER: "You have people at the FDA who are legacy employees of the FDA, who have legacy relationships with big pharma... It's a revolving door." And: "over 60% of the FDA's funding is based off fee schedules. And those fee schedules generate the revenue that create your jobs."

Those fees exist because of the 1992 Prescription Drug User Fee Act, which let the FDA take money from the drug makers whose products it approves.

It was created during the AIDS crisis to speed up emergency treatments. By 2022, user fees made up 46% of the FDA's budget, and roughly 65% of the money for regulating human drugs.

What did the money buy? Speed. Approval times fell from 29 months in 1987 to 10 months in 2018. But before the act, 21% of drugs were later pulled or given a black box warning. Afterward, that rose to 27%, partly because senior FDA officials overturned their own scientists.

Trying to make simple COVID treatments available to the public showed me that no authority or journal was interested in off-patent drugs that saved lives. This article shows where all that corruption comes from and exactly how Pharma bribes everyone.

Six peptides are back because an HHS Secretary pushed back on the FDA. Give me (@MidwesternDoc) a follow and visit me on Substack!

The bigger problem is nobody owns BPC-157, so nobody's going to pay for the human trials that would settle whether it works.

Big victory for medical autonomy over Pharma ghouls.

THE USA GOVT AGENCIES SUCH AS THE FDA, CDC, NIH, ETC., ARE RIFE WITH CORRUPT AND STUPID EMPLOYEES! REDUCE THE SIZE OF GOVT TO GET THESE PEOPLE OUT! @POTUS @VP @SecScottBessent @SecScottBessent @DHSgov

Worth knowing what "again" means here: it's enforcement discretion for licensed compounders on six peptides (BPC-157, TB-500, MOTS-c, KPV, semax, epitalon), not FDA approval. The rule that makes it stick is still being written.

Peptides have changed my life this year, and that is not an understatement. BPC-157 being one of them. And I thankfully have found a few ways to not have to inject all of them. Took a lot of research and time to figure it out. But worth it - my chronic pain is almost gone.

Abolish all 3 letter agencies, they are stealing our freedoms and trying to kill us.